An investigator-initiated, open-label, single-center, proof-of-concept-study of omalizumab in patients with poorly controlled acute urticaria

Publication date: Available online 19 March 2017 Source:Dermatologica Sinica Author(s): Hsien-Yi Chiu, Chih-Chieh Chan, Chia-Yu Chu, Tsen-Fang Tsai

Source: Dermatologica Sinica - March 18, 2017 Category: Dermatology Source Type: research